ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M01AB05 | G | Diclofenac sodium - 50mg | 7664 | 185966/13 | OLFEN-50 | 50mg | 20 | Tablet, gastroresistant | Oral | Mectapharm S.A.L. | Acino Pharma AG | Switzerland | 248,611 L.L | 23.08 | A1 | Acino Pharma AG | Switzerland | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M01AB05 | G | Diclofenac sodium - 50mg | 1822 | 28589 | DICLOGESIC | 50mg | 20 | Tablet, enteric coated | Oral | Sadco | Dar Al Dawa | Jordan | 205,608 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
M01AB05 | G | Diclofenac sodium - 50mg | 4595 | 19266 | EPARDEX | 50mg | 30 | Tablet, enteric coated | Oral | Pharmadex | Pharmadex | Lebanon | 223,974 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
M01AB05 | G | Diclofenac sodium - 50mg | 11183 | 130722/1 | EPARDEX | 50mg | 500 | Tablet, enteric coated | Oral | Pharmadex | Pharmadex | Lebanon | 3,246,979 L.L | 23.08 | B | 2/5/2024 | 0 | ||
M01AB05 | G | Diclofenac sodium - 50mg | 1278 | 27796 | GROFENAC | 50mg | 20 | Tablet | Oral | Mediterranean Pharmaceutical Company | Dr Grossmann AG Pharmaca | Switzerland | 260,705 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
M01AB05 | G | Diclofenac sodium - 50mg | 9479 | 183017/1 | PRIMAFENAC | 50mg | 30 | Tablet, enteric coated | Oral | Prime Pharma SAL | Pharmadex | Lebanon | 223,974 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
M01AB05 | G | Diclofenac sodium - 50mg | 6320 | 195461/04 | REMETHAN | 50mg | 20 | Tablet | Oral | Droguerie Columbus | Remedica Ltd | Cyprus | 196,201 L.L | 23.08 | A1 | 2/5/2024 | 0 |